benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate

C32H35N3O4 — CID 66573468

IUPACbenzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate
SMILESCC(C)N(C(=O)[C@@H]1Cc2ccccc2CN1C(=O)OCc1ccccc1)c1ccc(N2CCCCC2=O)cc1
InChIInChI=1S/C32H35N3O4/c1-23(2)35(28-17-15-27(16-18-28)33-19-9-8-14-30(33)36)31(37)29-20-25-12-6-7-13-26(25)21-34(29)32(38)39-22-24-10-4-3-5-11-24/h3-7,10-13,15-18,23,29H,8-9,14,19-22H2,1-2H3/t29-/m0/s1
InChIKeyLQCJSOCZNRPZEW-LJAQVGFWSA-N
MW525.65 g/mol
LogP5.71
Rot. Bonds6

About benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate

benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate (PubChem CID 66573468) has the molecular formula C32H35N3O4 and a molecular weight of 525.65 g/mol. Its IUPAC name is benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate.

Molecular Properties

Compound Namebenzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate
PubChem CID66573468
Molecular FormulaC32H35N3O4
Molecular Weight525.65 g/mol
Exact Mass525.26
IUPAC Namebenzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate
SMILESCC(C)N(C(=O)[C@@H]1Cc2ccccc2CN1C(=O)OCc1ccccc1)c1ccc(N2CCCCC2=O)cc1
InChIInChI=1S/C32H35N3O4/c1-23(2)35(28-17-15-27(16-18-28)33-19-9-8-14-30(33)36)31(37)29-20-25-12-6-7-13-26(25)21-34(29)32(38)39-22-24-10-4-3-5-11-24/h3-7,10-13,15-18,23,29H,8-9,14,19-22H2,1-2H3/t29-/m0/s1
InChIKeyLQCJSOCZNRPZEW-LJAQVGFWSA-N
XLogP5.71
TPSA70.16 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500525.65
LogP ≤ 55.71
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Analyze benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate?
The IUPAC name of benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate (CID 66573468) is benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate.
What is the SMILES notation for benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate?
The canonical SMILES for benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate is CC(C)N(C(=O)[C@@H]1Cc2ccccc2CN1C(=O)OCc1ccccc1)c1ccc(N2CCCCC2=O)cc1.
What is the InChIKey of benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate?
The InChIKey is LQCJSOCZNRPZEW-LJAQVGFWSA-N. The full InChI is InChI=1S/C32H35N3O4/c1-23(2)35(28-17-15-27(16-18-28)33-19-9-8-14-30(33)36)31(37)29-20-25-12-6-7-13-26(25)21-34(29)32(38)39-22-24-10-4-3-5-11-24/h3-7,10-13,15-18,23,29H,8-9,14,19-22H2,1-2H3/t29-/m0/s1.
What are the key properties of benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate?
benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate has a molecular weight of 525.65 g/mol, XLogP of 5.71, 6 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for benzyl (3S)-3-[[4-(2-oxopiperidin-1-yl)phenyl]-propan-2-ylcarbamoyl]-3,4-dihydro-1H-isoquinoline-2-carboxylate is sourced from PubChem (CID 66573468), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).